Neurogene (NGNE) Assets Average (2014 - 2026)

Neurogene's Assets Average history runs 13 years deep, the most recent figure standing at $275.9 million for Q1 2026.

• Quarterly Assets Average fell 15.25% year-over-year to $275.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $275.9 million (down 15.25% YoY) and the FY2025 annual result came in at $312.2 million, up 11.83% from the prior year.
• Assets Average was $275.9 million for Q1 2026 at Neurogene, down from $288.2 million in the prior quarter.
• Across five years, Assets Average topped out at $325.5 million in Q1 2025 and bottomed at $91.8 million in Q3 2023.
• A 5-year average of $194.3 million and a median of $172.0 million in 2024 frame the typical range for Assets Average.
• Annual changes were most pronounced in 2023 — Assets Average sank 33.5% — and 2024, when it jumped 101.19%.
• Neurogene's Assets Average stood at $117.9 million in 2022, then soared by 32.36% to $156.1 million in 2023, then surged by 60.13% to $249.9 million in 2024, then advanced by 15.32% to $288.2 million in 2025, then declined by 4.28% to $275.9 million in 2026.
• Business Quant data shows NGNE's Assets Average at $275.9 million in Q1 2026, $288.2 million in Q4 2025, and $292.6 million in Q3 2025.